Testing effectiveness (Phase 2)Ended earlyNCT00325078
What this trial is testing
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
Who this might be right for
Chronic Granulomatous DiseaseCrohn'S-like IBDInflammatory Bowel Disease (IBD)
National Institute of Allergy and Infectious Diseases (NIAID) 40